Patents
Literature
Patsnap Copilot is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Patsnap Copilot

306 results about "Protocatechuic acid" patented technology

Protocatechuic acid (PCA) is a dihydroxybenzoic acid, a type of phenolic acid. It is a major metabolite of antioxidant polyphenols found in green tea. It has mixed effects on normal and cancer cells in in vitro and in vivo studies.

Inhibitors and Enhancers of Uridine Diphosphate-Glucuronosyltransferase 2B (UGT2B)

A UGT2B inhibitor capable of increasing the bio-availability of a drug, is a compound in a free base or a pharmaceutically acceptable salt form that is selected from the group consisting of: capillarisin, isorhamnetin, β-naphthoflavone, α-naphthoflavone, hesperetin, terpineol, (+)-limonene, β-myrcene, swertiamarin, eriodictyol, cineole, apigenin, baicalin, ursolic acid, isovitexin, lauryl alcohol, puerarin, trans-cinnamaldehyde, 3-phenylpropyl acetate, isoliquritigenin, paeoniflorin, gallic acid, genistein, glycyrrhizin, protocatechuic acid, ethyl myristate, umbelliferone, PEG (Polyethylene glycol) 400, PEG 2000, PEG 4000, Tween 20, Tween 60, Tween 80, BRIJ® 58, BRIJ® 76, Pluronic® F68, Pluronic® F127, and a combination thereof. A UGT2B enhancer capable of enhancing a clearance rate of morphine-like analgesic agents, is a compound in a free base or a pharmaceutically acceptable salt form that is selected from the group consisting of: nordihydroguaiaretic acid, wogonin, trans-cinnamic acid, baicalein, quercetin, daidzein, oleanolic acid, homoorientin, hesperetin, narigin, neohesperidin, (+)-epicatechin, hesperidin, liquiritin, eriodictyol, formononetin, quercitrin, genkwanin, kaempferol, isoquercitrin, (+)-catechin, naringenin, daidzin, (−)-epicatechin, luteolin-7-glucoside, ergosterol, rutin, luteolin, ethyl myristate, apigenin, 3-phenylpropyl acetate, umbelliferone, glycyrrhizin, protocatechuic acid, poncirin, isovitexin, 6-gingerol, cineole, genistein, trans-cinnamaldehyde, and a combination thereof.
Owner:NAT DEFENSE MEDICAL CENT

Green tea extract-ferroferric oxide composite catalyst and application thereof

The invention discloses a green tea extract-ferroferric oxide composite catalyst and application thereof. A preparation method of the green tea extract-ferroferric oxide composite catalyst comprises the steps of dissolving FeCl3.6H2O, sodium acetate and polyethylene glycol into ethylene glycol, then placing the mixture into a reaction kettle, raising the temperature to 195-205 DEG C, preserving the temperature for 8-72 hours, and then conducting natural cooling to reach the room temperature, so that black solid is obtained; cleaning the black solid with ethanol and ultra-pure water respectively, and conducting vacuum drying, so that ferroferric oxide powder is obtained; weighing ferroferric oxide and green tea extract according to the mass ratio of 1: 5-5: 1, placing the ferroferric oxide and the green tea extract in the ultra-pure water, conducting ultrasonic treatment for 0.5-2 hours, and conducting solid-liquid separation; conducting vacuum drying on obtained solid, so that the green tea extract-ferroferric oxide composite catalyst is obtained, wherein the green tea extract is one or more of protocatechuic acid, epigallocatechin, gallate and epicatechin. The green tea extract has great reductibility, and ferroferric oxide catalysis efficiency can be improved; the composite catalyst is green and environmentally friendly and convenient to separate, and secondary pollution cannot be caused.
Owner:HUNAN UNIV

Quality control method for simultaneous realization of content analysis and similarity evaluation of 18 components in Ilex kudingcha

ActiveCN106198782ARealize simultaneous content determinationComprehensive evaluationComponent separationIlex kudingchaHydroxytyrosol
The invention discloses a quality control method for simultaneous realization of content analysis and similarity evaluation of 18 components in Ilex kudingcha. Rutin, isochlorogenic acid A and kudinoside A are used as internal references; correction factors of rutin for 6-hydroxy-7,7a-dihydro-2(6H)-benzofuran and hydroxytyrosol glucoside, correction factors of isochlorogenic acid A for protocatechuic acid, kudinoside E, kudinoside D, neochlorogenic acid, chlorogenic acid, cryptochlorogenic acid, caffeic acid, isochlorogenic acid B, and isochlorogenic acid C, and correction factors of kudinoside A for latifoloside G, kudinoside G, ilex kudingcha ilexoside T and latifoloside H are calculated, and the factors are used as constants for determining content. Only three common reference substances are needed for simultaneous determination of contents of 18 kinds of components in ilex kudingcha, quality of the ilex kudingcha can be rapidly, economically and scientifically controlled, and further cluster analysis, main component analysis and similarity calculation of medicinal materials can be carried out by using contents of the 18 kinds of components, in order to comprehensively control quality of ilex kudingcha.
Owner:GUANGZHOU UNIVERSITY OF CHINESE MEDICINE

Novel method for simultaneously measuring contents of multiple active ingredients of dogwood

The invention discloses a novel method for simultaneously measuring contents of multiple active ingredients of dogwood. The method is used for simultaneously measuring the contents of seven ingredients, namely loganin, gallic acid, 5-HMF (hydroxymethyl furfural), protocatechuic acid, morroniside, sweroside and cor-nuside, in dogwood medicinal materials from four main producing areas by utilizing a high performance liquid diode array detection method. The method comprises the steps of: carrying out gradient elution at the flow speed of 1.0 mL.min-1 by utilizing a Phenoemenex C18 polar chromatographic column and taking acetonitrile and 0.1% methanoic acid solution as mobile phases, wherein the column temperature is 30 DEG C, the detection wavelengths are 220 nm, 240 nm, 260 nm, 265 nm and 280 nm. The contents of the loganin, the gallic acid, the 5-HMF, the protocatechuic acid, the morroniside, the sweroside and the cor-nuside in each sample are respectively 0.22-0.800 mg/g, 0.002-0.024 mg/g, 0.069-3.775 mg/g, 8.192-28.111 mg/g, 0.048-0.598 mg/g, 1.228-9.311 mg/g and 1.450-8.381 mg/g. The method is simple and accurate, is good in reproducibility and is capable of providing bases for comprehensively evaluating and controlling the quality of dogwood decoction pieces.
Owner:SHAANXI NORMAL UNIV

Method for measuring danshensu, m-methyl-danshensu, protocatechualdehyde, and protocatechuic acid in human blood plasma

The invention relates to a method for measuring drug contents, particularly to a method for measuring danshensu, m-methyl-danshensu, protocatechualdehyde, and protocatechuic acid in the human blood plasma. The method comprises the following steps: 1) preparation of reference substance storing solutions: weighting reference substances of danshensu, m-methyl-danshensu, protocatechualdehyde, and protocatechuic acid, and dissolving the reference substances with methanol to obtain reference substance storing solutions of danshensu, m-methyl-danshensu, protocatechualdehyde, and protocatechuic acid; 2) preparation of an internal standard solution: dissolving an internal standard substance of vanillic acid with methanol to obtain the internal standard solution; 3) a treatment method of a blood plasma sample: taking the blood plasma sample, adding the internal standard solution, methanol, hydrochloric acid, and ethyl acetate into the blood plasma sample, performing uniform mixing, performing centrifugation of the obtained mixture to obtain a supernatant ethyl acetate layer, drying the ethyl acetate layer, re-dissolving the ethyl acetate layer with methanol, and performing centrifugation of the obtained solution to obtain supernatant liquid of the blood plasma sample; and 4) content measurement: by adopting LC-MS/MS chromatography, injecting the reference substance storing solutions and the supernatant liquid of the blood plasma sample into a chromatographic instrument to obtain a chromatogram, and calculating concentrations of danshensu, m-methyl-danshensu, protocatechualdehyde, and protocatechuic acid in the human blood plasma according to the areas of chromatographic peaks in the chromatogram.
Owner:TIANJIN TASLY PHARMA CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products